Carol Schafer - Net Worth and Insider Trading

Carol Schafer Net Worth

The estimated net worth of Carol Schafer is at least $27,180 dollars as of 2024-04-25. Carol Schafer is the Director of Repare Therapeutics Inc and owns about 8,000 shares of Repare Therapeutics Inc (RPTX) stock worth over $25,280. Carol Schafer is also the Director of Aceragen Inc and owns about 5,000 shares of Aceragen Inc (ACGN) stock worth over $1,900. Details can be seen in Carol Schafer's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Carol Schafer has not made any transactions after 2020-06-23 and currently still holds the listed stock(s).

Transaction Summary of Carol Schafer

To

Carol Schafer Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Carol Schafer owns 6 companies in total, including Aceragen Inc (ACGN) , Repare Therapeutics Inc (RPTX) , and Five Prime Therapeutics Inc (FPRX) among others .

Click here to see the complete history of Carol Schafer’s form 4 insider trades.

Insider Ownership Summary of Carol Schafer

Ticker Comapny Transaction Date Type of Owner
ACGN Aceragen Inc 2019-10-01 director
RPTX Repare Therapeutics Inc 2020-06-23 director
FPRX Five Prime Therapeutics Inc 2020-05-14 director
INSM Insmed Inc 2020-04-01 director
LXRX Lexicon Pharmaceuticals Inc 2003-12-01 VP Finance - Communications
KURA Kura Oncology Inc 2021-06-03 director

Carol Schafer Latest Holdings Summary

Carol Schafer currently owns a total of 2 stocks. Among these stocks, Carol Schafer owns 8,000 shares of Repare Therapeutics Inc (RPTX) as of June 23, 2020, with a value of $25,280 and a weighting of 93.01%. Carol Schafer also owns 5,000 shares of Aceragen Inc (ACGN) as of December 19, 2018, with a value of $1,900 and a weighting of 6.99%.

Latest Holdings of Carol Schafer

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
RPTX Repare Therapeutics Inc 2020-06-23 8,000 3.16 25,280
ACGN Aceragen Inc 2018-12-19 5,000 0.38 1,900

Holding Weightings of Carol Schafer


Carol Schafer Form 4 Trading Tracker

According to the SEC Form 4 filings, Carol Schafer has made a total of 1 transactions in Repare Therapeutics Inc (RPTX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Repare Therapeutics Inc is the acquisition of 8,000 shares on June 23, 2020, which cost Carol Schafer around $160,000.

According to the SEC Form 4 filings, Carol Schafer has made a total of 0 transactions in Aceragen Inc (ACGN) over the past 5 years. The most-recent trade in Aceragen Inc is the acquisition of 5,000 shares on December 19, 2018, which cost Carol Schafer around $16,650.

Insider Trading History of Carol Schafer

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Carol Schafer Trading Performance

GuruFocus tracks the stock performance after each of Carol Schafer's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Carol Schafer is -7.37%. GuruFocus also compares Carol Schafer's trading performance to market benchmark return within the same time period. The performance of stocks bought by Carol Schafer within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Carol Schafer's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Carol Schafer

Average Return

Outperforming Transactions

Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -24.57 -7.37 -9.19 -28.55 -11.84 -36.9
Relative Return to S&P 500(%) -29.5 -15.55 -26.47 -60.21 -27.71 -54

Carol Schafer Ownership Network

Ownership Network List of Carol Schafer

No Data

Ownership Network Relation of Carol Schafer


Carol Schafer Owned Company Details

What does Aceragen Inc do?

Who are the key executives at Aceragen Inc?

Carol Schafer is the director of Aceragen Inc. Other key executives at Aceragen Inc include director & President & CEO Vincent Milano , director & 10 percent owner Pillar Invest Corp , and 10 percent owner Atul Chopra .

Aceragen Inc (ACGN) Insider Trades Summary

Over the past 18 months, Carol Schafer made no insider transaction in Aceragen Inc (ACGN). Other recent insider transactions involving Aceragen Inc (ACGN) include a net sale of 264,324 shares made by Atul Chopra , a net purchase of 21,147 shares made by Pillar Invest Corp , and a net sale of 3,283 shares made by Vincent Milano .

In summary, during the past 3 months, insiders sold 0 shares of Aceragen Inc (ACGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 273,476 shares of Aceragen Inc (ACGN) were sold and 26,965 shares were bought by its insiders, resulting in a net sale of 246,511 shares.

Aceragen Inc (ACGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Aceragen Inc Insider Transactions

No Available Data

Carol Schafer Mailing Address

Above is the net worth, insider trading, and ownership report for Carol Schafer. You might contact Carol Schafer via mailing address: 42 White Street, Fourth Floor, New York Ny 10013.

Discussions on Carol Schafer

No discussions yet.